|
Roche in 2011: Strong results and positive outlook
|
07 February 2012 |
|
Roche supports cancer care development program in Ethiopia
|
23 January 2012 |
|
FDA Commissioner Announces Final Decision on Avastin for Metastatic Breast Cancer
|
21 November 2011 |
|
Roche reports positive study of Herceptin given by subcutaneous injection
|
19 October 2011 |
|
Roche achieves significant progress with personalised healthcare
|
14 October 2011 |
|
Roche's investigational medicine T-DM1 shows improvement in progression-free survival
|
26 September 2011 |
|
Roche named Dow Jones Sustainability Index leader in healthcare for third consecutive year
|
12 September 2011 |
|
Roche’s Tarceva receives European approval for first-line use in a genetically distinct type of lung cancer
|
06 September 2011 |
|
FDA approves Zelboraf and companion diagnostic for BRAF mutation-positive metastatic melanoma
|
18 August 2011 |
|
Roche's investigational treatment for asthma met its primary endpoint
|
08 August 2011 |
|
"Roche Continents" at the Salzburg Festival celebrates its five-year anniversary
|
28 July 2011 |
|
Roche to provide HIV/AIDS tests for Early Infant Diagnosis in South Africa
|
26 July 2011 |
|
Roche provides update from FDA hearing on Avastin for metastatic breast cancer
|
14 July 2011 |
|
Pivotal study showed vismodegib helped shrink tumours or heal lesions
|
21 June 2011 |
|
RoACTEMRA could change the current standard of treatment for people living with rheumatoid arthritis
|
30 May 2011 |
|
Roche to present significant progress in advanced skin, lung and ovarian cancers at ASCO
|
19 May 2011 |
|
New drug applications submitted in the United States and Europe for vemurafenib in advanced skin cancer
|
13 May 2011 |
|
Roche Group's first-quarter 2011 sales on track for full-year targets
|
18 April 2011 |
|
Roche announces positive pivotal Phase II results for Hedgehog Pathway Inhibitor
|
22 March 2011 |
|
Roche Annual General Meeting: dividend raised by 10%
|
01 March 2011 |